Progression prediction of coronary artery lesions by echocardiography-based ultrasomics analysis in Kawasaki disease

• Published in: Italian journal of pediatrics 2024-09, Vol.50 (1), p.185-10, Article 185
• Main Authors: Xu, Dan, Feng, Chen-Hui, Cao, Ai-Mei, Yang, Shuai, Tang, Zhen-Chao, Li, Xiao-Hui
• Format: Article
• Language: English
• Subjects: Child, Preschool; Coronary Artery Disease - diagnostic imaging; Coronary artery lesions; Disease Progression; Echocardiogram; Echocardiography; Female; Humans; Infant; Kawasaki disease; Male; Mucocutaneous Lymph Node Syndrome - diagnostic imaging; Pediatric; Predictive Value of Tests; Prospective Studies; Retrospective Studies; Ultrasomics
• ISSN: 1824-7288; 1824-7288
• DOI: 10.1186/s13052-024-01739-1

Echocardiography-based ultrasomics analysis aids Kawasaki disease (KD) diagnosis but its role in predicting coronary artery lesions (CALs) progression remains unknown. We aimed to develop and validate a predictive model combining echocardiogram-based ultrasomics with clinical parameters for CALs progression in KD. Total 371 KD patients with CALs at baseline were enrolled from a retrospective cohort (cohort 1, n = 316) and a prospective cohort (cohort 2, n = 55). CALs progression was defined by increased Z scores in any coronary artery branch at the 1-month follow-up. Patients in cohort 1 were split randomly into training and validation set 1 at the ratio of 6:4, while cohort 2 comprised validation set 2. Clinical parameters and ultrasomics features at baseline were analyzed and selected for models construction. Model performance was evaluated by area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC) and decision curve analysis (DCA) in the training and two validation sets. At the 1-month follow-ups, 65 patients presented with CALs progression. Three clinical parameters and six ultrasomics features were selected to construct the model. The clinical-ultrasomics model exhibited a good predictive capability in the training, validation set 1 and set 2, achieving AUROCs of 0.83 (95% CI, 0.75-0.90), 0.84 (95% CI, 0.74-0.94), and 0.73 (95% CI, 0.40-0.86), respectively. Moreover, the AUPRC values and DCA of three model demonstrated that the clinical-ultrasomics model consistently outperformed both the clinical model and the ultrasomics model across all three sets, including the training set and the two validation sets. Our study demonstrated the effective predictive capacity of a prediction model combining echocardiogram-based ultrasomics features and clinical parameters in predicting CALs progression in KD.